Acyclovir Sodium Injectable Recalled for Particulate Matter
AuroMedics Pharma is recalling Acyclovir Sodium injection due to dark red, brown, and black particulate matter found in vials. Approximately 89,400 vials were distributed nationwide.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: This recall involves particulate contamination in an injectable medication, which constitutes a risk-of-harm product. Although no illnesses or injuries have been reported, the presence of particulate matter in an intravenous injection poses potential risk to patients if administered.
Plain-English summary
AuroMedics Pharma LLC is recalling Acyclovir Sodium Injection, 500mg/10mL (50mg/mL), distributed nationwide. The recall was initiated following customer complaints of dark red, brown, and black particulate matter floating inside vials.
The affected product is Lot AC22006 with an expiration date of 08/2023. Approximately 89,400 vials of the 10 mL single-dose vials were distributed throughout the USA. The product is manufactured in India and distributed by AuroMedics Pharma LLC in E. Windsor, New Jersey.
Patients and healthcare providers should immediately discontinue use of affected vials from this lot. Individuals who have received an injection from an affected vial should contact their healthcare provider for medical evaluation and guidance on alternative acyclovir products or treatment options.
The recalled product
- Product
- ACYCLOVIR SODIUM (ACYCLOVIR SODIUM)
- Brand
- ACYCLOVIR SODIUM
- Manufacturer
- AuroMedics Pharma LLC
- Category
- Drug — Injectable / Intravenous
- Hazard
- particulate-matter
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot: AC22006
- Exp 08/2023
UPCs (2)
- 0355150155200
- 0355150154104
Distribution
Distributed nationwide across the United States.
Related recalls
Same brand · ACYCLOVIR SODIUM
- HighInjectable Acyclovir Sodium Recalled for Particulate Matter Contamination
FDA (Drugs) · 2023-01-11
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateSensipar (Cinacalcet Hydrochloride) Tablets Recalled for CGMP Deviations
FDA (Drugs) · 2026-07-01
- ModerateSensipar cinacalcet hydrochloride tablets recalled for CGMP deviations
FDA (Drugs) · 2026-07-01
- ModerateCorlanor ivabradine tablets recalled for presence of foreign substance
FDA (Drugs) · 2026-07-01
- ModerateSensipar Cinacalcet Tablets Recalled Due to CGMP Deviations
FDA (Drugs) · 2026-07-01